Previous 10 | Next 10 |
The World Health Organization ((WHO)) has granted an emergency use listing for the COVID-19 vaccine developed by Sinovac Biotech (SVA) making it the second Chinese coronavirus vaccine to win the WHO nod.The decision was supported by data indicating that the “inactivatedȁ...
Pfizer (PFE)/BioNTech (BNTX) and AstraZeneca (AZN) are set to lead the global COVID-19 vaccine supplies for 2021, estimates from Airfinity Ltd. indicate.By the end of the year, the production of COVID-19 vaccines could reach ~11.1B doses across the world, London-based research company pr...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
The World Health Organization ((WHO)) has asked for more data on Sinovac Biotech's (SVA) CoronaVac, before deciding whether to authorize a second Chinese COVID-19 vaccine for global use, WSJ reports.The company is asked to submit more details regarding the safety of the shot and manufacturing...
The WHO approved Sinopharm's COVID-19 vaccine for emergency use, which will give poorer nations access to a vaccine against the global pandemic. CoronaVac is the first China-developed COVID-19 vaccine under consideration in Europe, joining vaccines from CureVac, Novavax and a Russian ...
The European Medicines Agency (EMA) has started a real-time review of the OVID-19 vaccine (Vero Cell) developed by Sinovac Biotech (SVA).According to Reuters, Sinovac's vaccine is the first from a Chinese developer to undergo EMA’s rolling review and the fourth currently unde...
Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2020 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2020. Th...
Sinovac Biotech's (SVA) CoronaVac COVID-19 vaccine was 67% effective in preventing symptomatic infection, according to real-world data from Chile, Reuters reports.A report from the Chilean health ministry found that the vaccine is 80% effective in preventing death and 85% effective against ho...
In a very surprising statement, Gao Fu (the head of the Chinese Center for Disease Control and Prevention) said at a conference in Chengdu over the weekend that the protection figures of the Chinese vaccines are "not high". The “Sputnik-V” vaccine from the Gamaleya Insti...
Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the third production line of CoronaVac®, its COVID-19 vaccine, was completed and put into commercial producti...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- LONDON, Ontario; BOSTON, Massachusetts – TheNewswire – May 1, 2024, Sernova Corp. (“Sernova” or the “Corporation”) (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH) a clinical-stage biotechnology company focused on the development of regenerativ...
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2023 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2023. The annual r...
--News Direct-- Dr. Philip Toleikis to retire as of April 30, 2024 Cost savings from restructuring and strategic transformation anticipated to extend runway Board rebuild underway LONDON, Ontario; BOSTON, Massachusetts – TheNewswire - April 25, 2024 –...